<p>Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study</p>-Reference-Cited by-同舟云学术

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

Published:2020-04 Issue: Volume:Volume 12 Page:177-189
ISSN:1178-6981
Container-title:ClinicoEconomics and Outcomes Research
language:en
Short-container-title:CEOR

Author:

Torre Enrico,Bruno Giacomo M^ORCID,Di Matteo Sergio,Martinotti Chiara^ORCID,Valentino Maria Chiara^ORCID,Bottaro Luigi C,Colombo Giorgio L^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Reference44 articles.

1. ISTAT. National Institute of Statistics. Diabetes in Italy years 2000–2016. 2017. Available from: https://www.istat.it/en/files/2017/07/Report_Diabetes_En_def.pdf?title=Diabetes+in+Italy+-+24+Jul+2017+-+Full+text.pdf. Accessed January 30, 2018. English.

2. Osservatorio ARNO Diabete. Il profilo assistenziale della popolazione con diabete. Rapporto XXIII. 2015. Available from: http://osservatorioarno.cineca.org. Accessed December 7, 2015.

3. AMD. Le monografie degli annali. Focus su: Full Data Circle. Napoli: Idelson-Gnocchi; 2017.

4. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonilureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study;Diabetes Therapy;2024-03-01

2. Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study;Diabetes Therapy;2023-09-23

3. GLP-1 RAs in Spain: A Short Narrative Review of Their Use in Real Clinical Practice;Advances in Therapy;2023-02-23

4. Cost-Effectiveness of Dulaglutide Versus Liraglutide for Management of Type 2 Diabetes Mellitus in Iran;Value in Health Regional Issues;2022-11

5. Economic burden of diabetes-related hypoglycemia on patients, payors, and employers;Journal of Diabetes and its Complications;2021-06